Results For "APE"

From the helm: Amplia Therapeutics (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.

From the helm: Amplia Therapeutics (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.

From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.

From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.

From the helm: Argenica Therapeutics (ASX:AGN), Dr. Liz Dallimore, CEO & MD

From the helm: Argenica Therapeutics (ASX:AGN), Dr. Liz Dallimore, CEO & MD

From the helm: Cynata Therapeutics (ASX:CYP), Kilian Kelly, CEO

From the helm: Cynata Therapeutics (ASX:CYP), Kilian Kelly, CEO

Weekly Wrap 13 December: Key economic drivers shape market movements Blog Post

Weekly Wrap 29 November: Economic data shapes global market sentiment Blog Post

Bell Direct | Because with me, there’s no red tape

Weekly Wrap 12 June

Weekly Wrap 12 June

The Commercial Era of Space Has Arrived – ASX:MOON Page

Weekly Wrap 15 May Blog Post

Weekly Wrap 8 May

Weekly Wrap 8 May

Weekly Wrap 1 May Blog Post